Evaluation of six months sputum culture conversion as a surrogate endpoint in a multidrug resistant-tuberculosis trial

• Paul Meyvisch ,

  Roles Formal analysis, Methodology, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: paul.meyvisch@hotmail.com

  Affiliations Janssen Pharmaceutica, Beerse, Belgium, I-BioStat, Universiteit Hasselt, Diepenbeek, Belgium

  http://orcid.org/0000-0002-7248-4273

  ⨯
• Chrispin Kambili,

  Roles Writing – original draft, Writing – review & editing

  Affiliation Johnson & Johnson Global Services, Raritan, NJ, United States of America

  ⨯
• Koen Andries,

  Roles Writing – original draft, Writing – review & editing

  Affiliation Janssen Pharmaceutica, Beerse, Belgium

  ⨯
• Nacer Lounis,

  Roles Writing – original draft, Writing – review & editing

  Affiliation Janssen Pharmaceutica, Beerse, Belgium

  ⨯
• Myriam Theeuwes,

  Roles Writing – original draft, Writing – review & editing

  Current address: DURECT Corporation, Cupertino, CA, United States of America

  Affiliation Janssen Pharmaceutica, Beerse, Belgium

  ⨯
• Brian Dannemann,

  Roles Writing – original draft, Writing – review & editing

  Affiliation Janssen Research & Development, Titusville, NJ, United States of America

  ⨯
• An Vandebosch,

  Roles Writing – original draft, Writing – review & editing

  Affiliation Janssen Pharmaceutica, Beerse, Belgium

  ⨯
• Wim Van der Elst,

  Roles Formal analysis, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Janssen Pharmaceutica, Beerse, Belgium

  ⨯
• Geert Molenberghs,

  Roles Methodology, Writing – original draft, Writing – review & editing

  Affiliations I-BioStat, Universiteit Hasselt, Diepenbeek, Belgium, I-BioStat, KU Leuven, Leuven, Belgium

  ⨯
• Ariel Alonso

  Roles Formal analysis, Methodology, Writing – original draft, Writing – review & editing

  Affiliation I-BioStat, KU Leuven, Leuven, Belgium

  ⨯